Eli Lilly hits $1 trillion market value, a first for a health-care company by CNBC Markets | November 21, 2025 9:14 pm | US Markets The pharmaceutical giant Eli Lilly’s stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.
